…
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures for Greenland Mines Ltd (GRML.US) are limited, so its specific assets, operations and financials are not clearly documented in major filings. If the company is an exploration or mining issuer as its name implies, long-term growth drivers could include successful resource discovery, rising demand for critical minerals and completion of project development milestones, which may appeal to investors seeking upstream mineral exposure.
Material risks include exploration and development failure, pronounced commodity-price volatility, permitting and geopolitical uncertainty in Arctic jurisdictions, and potential financing and execution risk common to small-cap mining companies.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -10.55M | -6.15M | -0.71M | 1.56M | -1.11M |
| Net income | -10.55M | -6.15M | -0.71M | 1.23M | -1.11M |
| Selling general administrative | 6.51M | 5.54M | - | - | 0.29M |
| Selling and marketing expenses | - | - | - | - | 0.82M |
| Ebitda | -7.15M | -5.54M | -0.63M | -0.66M | - |
| Depreciation and amortization | - | - | - | - | 1.11M |
| Operating income | -7.15M | -5.54M | -0.63M | -0.66M | -1.11M |
| Other operating expenses | 7.15M | 5.54M | 0.63M | 0.66M | 1.11M |
| Interest expense | 2.31M | 0.36M | 0.08M | - | - |
| Tax provision | 0.00M | 0.00M | - | - | - |
| Net interest income | -3.49M | -0.36M | - | - | - |
| Income tax expense | - | - | - | 0.32M | - |
| Total revenue | 0.00M | 0.00M | - | - | - |
| Total operating expenses | 7.15M | 5.54M | 0.63M | 0.66M | 1.11M |
| Total other income expense net | -3.41M | -0.61M | -0.08M | 2.21M | 0.00M |
| Net income from continuing ops | -10.55M | -6.15M | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 9.59M | 2.46M | 2.19M | 118.25M | - |
| Intangible assets | 2.30M | 2.30M | 2.19M | - | - |
| Other current assets | 0.12M | 0.09M | 0.00M | 0.10M | - |
| Total liab | 0.13M | 1.27M | 1.62M | 4.93M | - |
| Total stockholder equity | 9.46M | 1.19M | 0.57M | 113.32M | - |
| Other current liab | 0.08M | 0.98M | 0.15M | 0.51M | - |
| Common stock | 0.01M | 0.00M | 0.00M | 117.36M | - |
| Capital stock | 0.52M | 0.00M | - | - | - |
| Retained earnings | -21.11M | -10.56M | -3.92M | -4.04M | - |
| Cash | 7.18M | 0.06M | 0.00M | 0.34M | - |
| Total current liabilities | 0.08M | 1.25M | 1.62M | 0.51M | - |
| Net debt | -7.18M | 0.21M | 1.46M | -0.34M | - |
| Short term debt | - | 0.27M | 1.47M | - | - |
| Short long term debt | - | 0.27M | - | - | - |
| Short long term debt total | - | 0.27M | 1.47M | - | - |
| Other stockholder equity | 30.05M | 11.75M | 4.49M | - | - |
| Total current assets | 7.29M | 0.16M | 0.01M | 0.44M | - |
| Accounts payable | 0.04M | 0.06M | - | - | - |
| Accumulated other comprehensive income | 0.52M | - | - | - | - |
| Non current assets total | 2.30M | 2.30M | 2.19M | 117.81M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Total cashflows from investing activities | - | -0.12M | 0.02M | -116.15M |
| Net borrowings | -0.58M | 2.18M | - | - |
| Total cash from financing activities | 12.97M | 3.00M | 0.51M | 116.98M |
| Net income | -10.55M | -6.15M | -0.71M | 1.23M |
| Change in cash | 7.11M | 0.06M | -0.34M | 0.34M |
| Begin period cash flow | 0.06M | 0.00M | 0.34M | 0.00M |
| End period cash flow | 7.18M | 0.06M | 0.00M | 0.34M |
| Total cash from operating activities | -5.86M | -2.82M | -0.61M | -0.49M |
| Issuance of capital stock | 13.01M | 0.17M | - | - |
| Other cashflows from investing activities | - | - | 0.04M | - |
| Other cashflows from financing activities | -0.04M | 0.66M | 0.25M | -3.34M |
| Capital expenditures | 0.00M | 0.12M | 0.00M | 0.00M |
| Change in working capital | -0.92M | 0.28M | 0.10M | 0.49M |
| Stock based compensation | 1.57M | 2.65M | - | - |
| Other non cash items | 5.62M | 3.05M | - | -2.21M |
| Free cash flow | -5.86M | -2.82M | -0.61M | -0.49M |
Sector: Basic Materials Industry: Other Precious Metals & Mining
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| GRML Greenland Mines Ltd |
0.27 7.03% |
4.11 | - | - | - | 0.18 |
| FNLPF Fresnillo PLC |
- -% |
33.24 | 12.70 | 13.95 | 4.78 | 5.66 |
| AGPPF Anglo American Platinum Limited |
- -% |
70.61 | 26.95 | 10.44 | 0.22 | 4.16 |
| ANGPY Valterra Platinum Limited |
0.49 4.20% |
12.17 | 25.75 | 10.13 | 0.21 | 4.04 |
| IMPUF Impala Platinum Holdings Limited |
- -% |
10.85 | 6.72 | 11.60 | 0.09 | 1.80 |
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
| Name | Title | Year Born |
|---|---|---|
| Dr. Joseph A. Sinkule Pharm.D. | Founder, CEO, Chairman of the Board & Secretary | 1954 |
| Mr. Jeffrey LeBlanc | Chief Financial Officer | 1977 |
| Dr. Shalom Z. Hirschman M.D. | Medical Advisor & Director | 1936 |
| Mr. Peter J. Moriarty | Chief Business Officer | 1950 |
| Dr. Bo Moller Stensgaard | President | 1975 |
| Dr. Miguel Chillon Rodriguez | Chief Scientific Officer & Consultant | 1966 |
| Dr. Gustavo L.A. Delendatti B.Sc (Hons), MAIG, Ph.D. | Vice President of Exploration | NA |
| Dr. Jakob Kløve Keiding | Chief Geologist | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.